Esperance Pharmaceuticals

Esperance Pharmaceuticals is developing a new class of targeted anticancer drugs that can selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell surface. These drugs can even kill cells known to be resistant to chemotherapy drugs.